|
Market Closed -
Nasdaq Stockholm
01:00:00 30/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 0.3755 SEK | +1.08% |
|
-10.38% | -54.70% |
| 10-21 | Alzinova Finalizes US Trial Sites for Mid-stage Alzheimer's Disease Vaccine Study | MT |
| 10-21 | Alzinova selects seven U.S. trial sites ahead of phase IIa study | FW |
Chart: Technical Analysis
Nasdaq StockholmSEK
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| ALZ | Delayed | |
Deutsche Boerse AG
| 78D | Delayed | |
|
Börse Stuttgart
| 78D | Delayed | |
|
CBOE
| Real-time | ||
|
CBOE
| Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 0.4255 | 0.8 | 0.819 |
| Spread/Res. | -11.75% | -53.06% | -54.15% |
| Spread/Supp. | +1.08% | +1.08% | +75.71% |
| Support | 0.3715 | 0.3715 | 0.2137 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ALZ Stock
- Charts Alzinova AB
Select your edition
All financial news and data tailored to specific country editions
